Experience
Medtronic Vascular Inc.
Abbott Vascular, Inc.
Represented Abbott in multiple patent litigations relating to its market-leading Vision™ bare-metal stent and Xience™ drug-eluting stent. Case settled on the Friday before jury selection, with Medtronic paying client Abbott $400 million to settle all global patent disputes.
Medtronic Vascular Inc. v. Abbott Vascular, Inc., 4:06-cv-01066, N.D. Cal., Judges Chen, Hamilton
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
Innolux Corporation v. Applied Materials, Inc.
Innolux Corporation
AGIS Software Development, LLC v. ZTE USA Inc. et al.
ZTE USA, Inc.
Uniloc USA Inc. et al. v. LG Electronics USA Inc. et al.
LG Electronics USA Inc. et al.
Uniloc USA Inc et al. v. LG Electronics U.S.A., Inc. et al.
LG Electronics U.S.A., Inc. et al.
Koninklijke Philips NV et al. v. Tongfang Global Inc. et al.
Koninklijke Philips NV et al.
WordLogic Corp. et al. v. TouchType, Inc. dba SwiftKey
TouchType, Inc. (d/b/a SwiftKey)
AbbVie Inc. et al v. Alvotech hf.
AbbVie Inc. et al
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.